Encrypted login | home

Program Information

  Broad and Interesting Therapy Topics Sunday - 7/30/2017
Therapy SNAP Oral 4:00 PM - 6:00 PM Room: Four Seasons 2

Moderator 1: Hajar Alipour, Shiraz University
Moderator 2: Michalis Aristophanous, UT MD Anderson Cancer Center

4:00 PM
SU-K-FS2-1 : A Cellular Automaton Model of Radiation Damage to the Tumor
E. Fourkal*, M. Guerra, M. Lamberto
4:07 PM
SU-K-FS2-2 : A Cortical Thickness Model to Predict Radiation-Induced Bone Fracture
M. Munley*, C. Okoukoni, E. McTyre, M. Farris, D. Randolph, A. Blackstock, J. Willey
4:14 PM
SU-K-FS2-3 : A Mathematical Model of Cancer Stem Cell Kinetics and Response to Radiation Therapy
H. Zhong*, K. Barton, B. Movsas, I. Chetty
4:21 PM
SU-K-FS2-4 : A New Sparse Optimization Scheme for Simultaneous Beam Angle and Fluence Optimization in Radiotherapy Planning
H. Liu*, P. Dong, L. Xing
4:28 PM
SU-K-FS2-5 : A Novel Method to Enhance Standard of Care Radiation Therapy: Cherenkov Light Activated Psoralen (CLAP)
S. Yoon*, V. Tsvankin, Z. Shrock, B. Meng, M. Dewhirst, P. Fecci, J. Adamson, M. Oldham
4:35 PM
SU-K-FS2-6 : A Stochastic Frontier Analysis for Enhanced Quality Control of High-Dose-Rate Brachytherapy Treatment Plans
P. Edimo*, L. Archambault, L. Beaulieu
4:42 PM
SU-K-FS2-7 : Analytic Solutions of the Two-Dimensional IMRT Inverse Planning Problem Under Flat-Depth-Dose Approximation and Implications for Beam-Number and Beam-Angle Optimization
F. Li*, G. Yan, J. Jung, B. Lu, J. Park, S. Lebron, S. Samant, J. Li, C. Liu
4:49 PM
SU-K-FS2-8 : Cherenkov Dosimetry Via Stopping-To-Cherenkov Power Ratios: Protocol and Experimental Feasibility
Y. Zlateva*, J. Seuntjens, I. El Naqa
4:56 PM
SU-K-FS2-9 : Dosimetric Evaluation of Pair Production Enhanced Radiotherapy (PPER) with the Use of High-Z Organometallics
P. Tsiamas*, D. Isrow, I. Chetty, J. Kim, S. Brown
5:03 PM
SU-K-FS2-10 : Evaluation of Energy Absorption by Bystander Gold Nanoparticles: A Microscopic Study
J. Kwon*, K. Sutherland, A. Makarova, T. Matsuura, T. Hashimoto, H. Peng, K. Umegaki, H. Shirato, S. Shimizu
5:10 PM
SU-K-FS2-11 : Fraction-Variant Beam Orientation Optimization for IMRT Based On Group Sparsity
D. O'Connor*, D. Nguyen, D. Ruan, V. Yu, K. Sheng
5:17 PM
SU-K-FS2-12 : Improved Normal Tissue Sparing by Limiting Jaw Opening During Volumetric Modulated Arc Therapy for Cancer of the Scalp
J. Zhang*, M. Leu, J. Cho-Lim, W. Inouye, S. Lee
5:24 PM
SU-K-FS2-13 : Pixel-Based Analysis of Stomach Dose-Surface Maps to Improve Toxicity Predictions in Gastrointestinal Radiotherapy
A. Witztum*, B. George, F. Van den Heuvel, M. Hawkins
5:31 PM
SU-K-FS2-14 : Radio-Dynamic Therapy Which Combines Cerenkov-Induced PDT and RT
Q. Zhang*, q. Sun, G. Xiao, J. ZENG, C. Ma, L. Chen
5:38 PM
SU-K-FS2-15 : Simulation of Cell Survival Probability and Chromosome Aberration Yields Based On a Nanodosimetric Monte Carlo Cell Nucleus Model
B. Lee*, C. Wang
5:45 PM
SU-K-FS2-16 : Singlet Oxygen Threshold Dose for Long-Term Tumor Control for BPD-Mediated PDT
M. Kim*, R. Penjweini, T. Zhu
5:52 PM
SU-K-FS2-17 : Using ROC Analysis to Determine the Optimal Lung Dosimetric Parameter as the Risk Factor of Survival for SBRT in NSCLC Patients
H. Yao*, W. Wang, F. Kong, J. Jin, D. Vile, Y. Liu, K. Shiue, A. Cerra-Franco, G. Bartlett, T. Lautenschlaeger